PLI scheme

Anil Matai, Director General, OPPI reflects on more than a decade of sweeping transformation under the leadership of Hon. Prime…

Production Linked Incentive Scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to…

The PRIP scheme has been launched with an outlay of ₹ 5,000 crore to transform India’s Pharma MedTech sector

Archana Jatkar, Associate Secretary General, IPA began her address by highlighting the dynamic challenges confronting the global…

The Ahmedabad Pharma Summit 2025 brought together policymakers, industry leaders, and innovators to explore pathways for global…

Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…

Dr Satish Wagh, Executive Chairman & Whole-Time Director, Supriya Lifesciences urges focused reforms in R&D, regulatory…

Focus on enabling MSME business, expanding PLI scheme and research-linked incentives to foster API innovation and tax incentives…

Under the PLI scheme for Bulk Drugs, a total of 48 projects have been selected under the scheme, of which 34 projects have been…

Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma invested ₹2,500 crores in its Penicillin-G (Pen-G) facility at…